Mead Johnson

Mead Johnson & Company, LLC is an American company that is a manufacturer of infant formula, both domestically and globally, with its best-known product Enfamil. It operates as an independent subsidiary of Reckitt.

The company dates back to a firm created by Edward Mead Johnson, one of the co-founders of Johnson & Johnson, who created his own business in 1895, which was renamed Mead Johnson & Company in 1905. The company was majority owned by Bristol-Myers Squibb after an acquisition in 1967, but was spun-off in 2009 as an independent firm. Almost all products are used by infants and children under 7 except Enfaschool which covers students from childhood to youth under 15 years.

In the year ending December 31, 2016, Mead Johnson reported net sales of $3.7 million, of which 50% was generated in Asia, 17% in Latin America and 33% in North America/Europe. For the same time period, the company reported total assets of $4.8 billion.

In February 2017, British consumer goods company Reckitt (then known as Reckitt Benckiser) bid $16.7 billion for the company. In June 2017, MJN announced that its merger with RB had been completed, which meant that MJN's common stock was no longer traded on the New York Stock Exchange.